Imazol Plus (Clotrimazole, Hexamidine Diisetionate)

Clotrimazole blocks the enzyme responsible for synthesising ergosterol, a key component of fungal cell membranes. Without ergosterol, the membrane becomes permeable, leading to fungal cell death. Hexamidine diisetionate adds antiseptic activity by disrupting microbial membranes.

The dosage regimen for Imazol Plus is determined by the prescribing clinician based on the infection type, severity and patient age. Typically, a thin layer is applied to the affected skin once or twice daily for the period advised by the healthcare professional.

Safety data for Imazol Plus in pregnancy and lactation are limited. Women who are pregnant, planning pregnancy or breastfeeding should discuss potential risks with their healthcare provider before using the product.

To order Imazol Plus, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Imazol Plus combines clotrimazole with hexamidine, offering both antifungal and antiseptic actions. Compared with single‑agent products such as terbinafine or miconazole, it may provide broader coverage against bacterial colonisation, though clinical choice depends on infection type, patient tolerance and physician preference.

Store Imazol Plus at room temperature, below 25 °C. Keep the container tightly closed, protect it from moisture and direct sunlight, and retain it in the original packaging until use.

Imazol Plus is applied topically to clean, dry skin. A thin film should be spread over the affected area and surrounding margin, usually once or twice daily as directed by a healthcare professional. Hands should be washed after application.

Serious risks, though rare, include severe allergic reactions such as contact dermatitis, urticaria, or bullous skin eruptions. If signs of a serious skin reaction or systemic symptoms develop, discontinue use and seek medical attention promptly.

Individuals with a known hypersensitivity to clotrimazole, hexamidine diisetionate or any excipients in the formulation should avoid Imazol Plus. It is also not recommended for use on extensive open wounds, mucous membranes or in patients where a clinician advises against topical antifungal therapy.